The global market for Amyotrophic Lateral Sclerosis Gene Testing was valued at US$ 120 million in the year 2024 and is projected to reach a revised size of US$ 209 million by 2031, growing at a CAGR of 7.5% during the forecast period.

Amyotrophic Lateral Sclerosis Gene Testing Market

Amyotrophic Lateral Sclerosis (ALS) Gene Testing is a molecular diagnostic technology used to identify whether an individual carries mutations associated with ALS. ALS is a neurodegenerative disorder that primarily affects motor neurons, resulting in muscle weakness, atrophy, and loss of motor function. Gene testing employs high-throughput sequencing, single nucleotide polymorphism (SNP) analysis, and targeted gene capture methods to detect mutations in known ALS-related genes, such as C9orf72, SOD1, TARDBP, and FUS. This technology provides a scientific basis for early clinical diagnosis, family genetic risk assessment, and personalized treatment planning, while also supporting novel targeted therapy development, drug screening, and clinical trial enrollment. With the advancement of precision medicine, ALS gene testing is evolving toward higher sensitivity, broader coverage, and automated data analysis.The average gross profit margin of this product is 45%.

The ALS gene testing market is growing rapidly due to increasing demand for neurodegenerative disease diagnostics and the adoption of precision medicine. Early diagnosis and familial ALS risk assessment drive clinical testing demand, while research institutions and pharmaceutical companies’ reliance on genetic data promotes the application of testing technologies. The maturity of high-throughput sequencing, targeted capture techniques, and bioinformatics platforms has enhanced sensitivity and coverage, providing strong technical support for clinical and research applications. Government support for rare and genetic diseases, along with growing patient awareness of early intervention and personalized treatment, also serve as key market growth drivers.ALS gene testing faces challenges such as high costs, lack of standardized testing protocols, and complex data interpretation. Different laboratory platforms and methods may lead to result variability, complicating clinical decision-making. The phenotypic heterogeneity and incomplete penetrance of ALS gene mutations introduce uncertainty in clinical applications. Furthermore, data privacy and ethical concerns, particularly regarding familial genetic information, impose additional requirements on the industry. Limited public awareness and restricted insurance coverage also constrain the widespread adoption of testing.

Downstream demand is increasingly focused on early diagnosis, risk prediction, and personalized intervention strategies. Clinical institutions, genetic counseling centers, and research organizations are expanding their use of ALS gene testing to support clinical decision-making and new drug development. The reliance of drug development and clinical trials on patient genotyping and precision enrollment further drives commercialization of testing services. As gene testing becomes more widespread, patient and family awareness of risk assessment and preventive interventions is rising, promoting the integration of genetic testing with health management.Upstream raw materials for ALS gene testing include high-throughput sequencing reagents, capture probes, PCR reagents, library preparation kits, and data analysis software and servers. The quality of sequencing chips and capture probes directly impacts test accuracy and coverage, representing core technical components. Major suppliers are concentrated in Europe, North America, and parts of the Asia-Pacific region, with mature production systems and quality control capabilities. Advances in biotechnology have improved reagent stability, automation, and data analysis capabilities, providing reliable support and efficient production for testing.

This report aims to provide a comprehensive presentation of the global market for Amyotrophic Lateral Sclerosis Gene Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amyotrophic Lateral Sclerosis Gene Testing.

The Amyotrophic Lateral Sclerosis Gene Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amyotrophic Lateral Sclerosis Gene Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, by Product Type and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Amyotrophic Lateral Sclerosis Gene Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Amyotrophic Lateral Sclerosis Gene Testing Market Report

Report Metric	Details
Report Name	Amyotrophic Lateral Sclerosis Gene Testing Market
Accounted market size in year	US$ 120 million
Forecasted market size in 2031	US$ 209 million
CAGR	7.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Targeted ALS Gene Panel Single-Gene Whole Exome Sequencing Whole Genome Sequencing
Segment by Product Type	IVD Kits Diagnostic Instruments Other
Segment by Sample	Blood/Serum Saliva Other
Segment by Application	Hospitals Third-party Laboratory Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Invitae, Quest Diagnostics, Labcorp, GeneDx, Centogene, Fulgent Genetics, Ambry Genetics, Baylor Genetics, Mayo Clinic Laboratories, NEALS Consortium Labs
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Product Type etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amyotrophic Lateral Sclerosis Gene Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Amyotrophic Lateral Sclerosis Gene Testing Market growing?

Ans: The Amyotrophic Lateral Sclerosis Gene Testing Market witnessing a CAGR of 7.5% during the forecast period 2025-2031.

What is the Amyotrophic Lateral Sclerosis Gene Testing Market size in 2031?

Ans: The Amyotrophic Lateral Sclerosis Gene Testing Market size in 2031 will be US$ 209 million.

Who are the main players in the Amyotrophic Lateral Sclerosis Gene Testing Market report?

Ans: The main players in the Amyotrophic Lateral Sclerosis Gene Testing Market are Invitae, Quest Diagnostics, Labcorp, GeneDx, Centogene, Fulgent Genetics, Ambry Genetics, Baylor Genetics, Mayo Clinic Laboratories, NEALS Consortium Labs

What are the Application segmentation covered in the Amyotrophic Lateral Sclerosis Gene Testing Market report?

Ans: The Applications covered in the Amyotrophic Lateral Sclerosis Gene Testing Market report are Hospitals, Third-party Laboratory, Others

What are the Type segmentation covered in the Amyotrophic Lateral Sclerosis Gene Testing Market report?

Ans: The Types covered in the Amyotrophic Lateral Sclerosis Gene Testing Market report are IVD Kits, Diagnostic Instruments, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Targeted ALS Gene Panel

1.2.3 Single-Gene

1.2.4 Whole Exome Sequencing

1.2.5 Whole Genome Sequencing

1.3 Market by Product Type

1.3.1 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth Rate by Product Type: 2020 VS 2024 VS 2031

1.3.2 IVD Kits

1.3.3 Diagnostic Instruments

1.3.4 Other

1.4 Market by Sample

1.4.1 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth Rate by Sample: 2020 VS 2024 VS 2031

1.4.2 Blood/Serum

1.4.3 Saliva

1.4.4 Other

1.5 Market by Application

1.5.1 Global Amyotrophic Lateral Sclerosis Gene Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Hospitals

1.5.3 Third-party Laboratory

1.5.4 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Amyotrophic Lateral Sclerosis Gene Testing Market Perspective (2020-2031)

2.2 Global Amyotrophic Lateral Sclerosis Gene Testing Growth Trends by Region

2.2.1 Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Amyotrophic Lateral Sclerosis Gene Testing Historic Market Size by Region (2020-2025)

2.2.3 Amyotrophic Lateral Sclerosis Gene Testing Forecasted Market Size by Region (2026-2031)

2.3 Amyotrophic Lateral Sclerosis Gene Testing Market Dynamics

2.3.1 Amyotrophic Lateral Sclerosis Gene Testing Industry Trends

2.3.2 Amyotrophic Lateral Sclerosis Gene Testing Market Drivers

2.3.3 Amyotrophic Lateral Sclerosis Gene Testing Market Challenges

2.3.4 Amyotrophic Lateral Sclerosis Gene Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Amyotrophic Lateral Sclerosis Gene Testing Players by Revenue

3.1.1 Global Top Amyotrophic Lateral Sclerosis Gene Testing Players by Revenue (2020-2025)

3.1.2 Global Amyotrophic Lateral Sclerosis Gene Testing Revenue Market Share by Players (2020-2025)

3.2 Global Top Amyotrophic Lateral Sclerosis Gene Testing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Amyotrophic Lateral Sclerosis Gene Testing Revenue

3.4 Global Amyotrophic Lateral Sclerosis Gene Testing Market Concentration Ratio

3.4.1 Global Amyotrophic Lateral Sclerosis Gene Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Gene Testing Revenue in 2024

3.5 Global Key Players of Amyotrophic Lateral Sclerosis Gene Testing Head office and Area Served

3.6 Global Key Players of Amyotrophic Lateral Sclerosis Gene Testing, Product and Application

3.7 Global Key Players of Amyotrophic Lateral Sclerosis Gene Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Amyotrophic Lateral Sclerosis Gene Testing Breakdown Data by Type

4.1 Global Amyotrophic Lateral Sclerosis Gene Testing Historic Market Size by Type (2020-2025)

4.2 Global Amyotrophic Lateral Sclerosis Gene Testing Forecasted Market Size by Type (2026-2031)

5 Amyotrophic Lateral Sclerosis Gene Testing Breakdown Data by Application

5.1 Global Amyotrophic Lateral Sclerosis Gene Testing Historic Market Size by Application (2020-2025)

5.2 Global Amyotrophic Lateral Sclerosis Gene Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Amyotrophic Lateral Sclerosis Gene Testing Market Size (2020-2031)

6.2 North America Amyotrophic Lateral Sclerosis Gene Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2020-2025)

6.4 North America Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size (2020-2031)

7.2 Europe Amyotrophic Lateral Sclerosis Gene Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2020-2025)

7.4 Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Amyotrophic Lateral Sclerosis Gene Testing Market Size (2020-2031)

8.2 Asia-Pacific Amyotrophic Lateral Sclerosis Gene Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Amyotrophic Lateral Sclerosis Gene Testing Market Size (2020-2031)

9.2 Latin America Amyotrophic Lateral Sclerosis Gene Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2020-2025)

9.4 Latin America Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size (2020-2031)

10.2 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Invitae

11.1.1 Invitae Company Details

11.1.2 Invitae Business Overview

11.1.3 Invitae Amyotrophic Lateral Sclerosis Gene Testing Introduction

11.1.4 Invitae Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

11.1.5 Invitae Recent Development

11.2 Quest Diagnostics

11.2.1 Quest Diagnostics Company Details

11.2.2 Quest Diagnostics Business Overview

11.2.3 Quest Diagnostics Amyotrophic Lateral Sclerosis Gene Testing Introduction

11.2.4 Quest Diagnostics Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

11.2.5 Quest Diagnostics Recent Development

11.3 Labcorp

11.3.1 Labcorp Company Details

11.3.2 Labcorp Business Overview

11.3.3 Labcorp Amyotrophic Lateral Sclerosis Gene Testing Introduction

11.3.4 Labcorp Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

11.3.5 Labcorp Recent Development

11.4 GeneDx

11.4.1 GeneDx Company Details

11.4.2 GeneDx Business Overview

11.4.3 GeneDx Amyotrophic Lateral Sclerosis Gene Testing Introduction

11.4.4 GeneDx Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

11.4.5 GeneDx Recent Development

11.5 Centogene

11.5.1 Centogene Company Details

11.5.2 Centogene Business Overview

11.5.3 Centogene Amyotrophic Lateral Sclerosis Gene Testing Introduction

11.5.4 Centogene Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

11.5.5 Centogene Recent Development

11.6 Fulgent Genetics

11.6.1 Fulgent Genetics Company Details

11.6.2 Fulgent Genetics Business Overview

11.6.3 Fulgent Genetics Amyotrophic Lateral Sclerosis Gene Testing Introduction

11.6.4 Fulgent Genetics Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

11.6.5 Fulgent Genetics Recent Development

11.7 Ambry Genetics

11.7.1 Ambry Genetics Company Details

11.7.2 Ambry Genetics Business Overview

11.7.3 Ambry Genetics Amyotrophic Lateral Sclerosis Gene Testing Introduction

11.7.4 Ambry Genetics Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

11.7.5 Ambry Genetics Recent Development

11.8 Baylor Genetics

11.8.1 Baylor Genetics Company Details

11.8.2 Baylor Genetics Business Overview

11.8.3 Baylor Genetics Amyotrophic Lateral Sclerosis Gene Testing Introduction

11.8.4 Baylor Genetics Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

11.8.5 Baylor Genetics Recent Development

11.9 Mayo Clinic Laboratories

11.9.1 Mayo Clinic Laboratories Company Details

11.9.2 Mayo Clinic Laboratories Business Overview

11.9.3 Mayo Clinic Laboratories Amyotrophic Lateral Sclerosis Gene Testing Introduction

11.9.4 Mayo Clinic Laboratories Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

11.9.5 Mayo Clinic Laboratories Recent Development

11.10 NEALS Consortium Labs

11.10.1 NEALS Consortium Labs Company Details

11.10.2 NEALS Consortium Labs Business Overview

11.10.3 NEALS Consortium Labs Amyotrophic Lateral Sclerosis Gene Testing Introduction

11.10.4 NEALS Consortium Labs Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

11.10.5 NEALS Consortium Labs Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Mayo Clinic Laboratories

NEALS Consortium Labs

List of Tables

Table 1. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Targeted ALS Gene Panel

Table 3. Key Players of Single-Gene

Table 4. Key Players of Whole Exome Sequencing

Table 5. Key Players of Whole Genome Sequencing

Table 6. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth Rate by Product Type (US$ Million): 2020 VS 2024 VS 2031

Table 7. Key Players of IVD Kits

Table 8. Key Players of Diagnostic Instruments

Table 9. Key Players of Other

Table 10. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth Rate by Sample (US$ Million): 2020 VS 2024 VS 2031

Table 11. Key Players of Blood/Serum

Table 12. Key Players of Saliva

Table 13. Key Players of Other

Table 14. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 15. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 16. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2020-2025) & (US$ Million)

Table 17. Global Amyotrophic Lateral Sclerosis Gene Testing Market Share by Region (2020-2025)

Table 18. Global Amyotrophic Lateral Sclerosis Gene Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 19. Global Amyotrophic Lateral Sclerosis Gene Testing Market Share by Region (2026-2031)

Table 20. Amyotrophic Lateral Sclerosis Gene Testing Market Trends

Table 21. Amyotrophic Lateral Sclerosis Gene Testing Market Drivers

Table 22. Amyotrophic Lateral Sclerosis Gene Testing Market Challenges

Table 23. Amyotrophic Lateral Sclerosis Gene Testing Market Restraints

Table 24. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue by Players (2020-2025) & (US$ Million)

Table 25. Global Amyotrophic Lateral Sclerosis Gene Testing Market Share by Players (2020-2025)

Table 26. Global Top Amyotrophic Lateral Sclerosis Gene Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Gene Testing as of 2024)

Table 27. Ranking of Global Top Amyotrophic Lateral Sclerosis Gene Testing Companies by Revenue (US$ Million) in 2024

Table 28. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis Gene Testing Revenue (CR5 and HHI) & (2020-2025)

Table 29. Global Key Players of Amyotrophic Lateral Sclerosis Gene Testing, Headquarters and Area Served

Table 30. Global Key Players of Amyotrophic Lateral Sclerosis Gene Testing, Product and Application

Table 31. Global Key Players of Amyotrophic Lateral Sclerosis Gene Testing, Date of Enter into This Industry

Table 32. Mergers & Acquisitions, Expansion Plans

Table 33. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Type (2020-2025) & (US$ Million)

Table 34. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue Market Share by Type (2020-2025)

Table 35. Global Amyotrophic Lateral Sclerosis Gene Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 36. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue Market Share by Type (2026-2031)

Table 37. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2020-2025) & (US$ Million)

Table 38. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue Market Share by Application (2020-2025)

Table 39. Global Amyotrophic Lateral Sclerosis Gene Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 40. Global Amyotrophic Lateral Sclerosis Gene Testing Revenue Market Share by Application (2026-2031)

Table 41. North America Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. North America Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2020-2025) & (US$ Million)

Table 43. North America Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2026-2031) & (US$ Million)

Table 44. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2020-2025) & (US$ Million)

Table 46. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2026-2031) & (US$ Million)

Table 47. Asia-Pacific Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 48. Asia-Pacific Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2020-2025) & (US$ Million)

Table 49. Asia-Pacific Amyotrophic Lateral Sclerosis Gene Testing Market Size by Region (2026-2031) & (US$ Million)

Table 50. Latin America Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 51. Latin America Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2020-2025) & (US$ Million)

Table 52. Latin America Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2026-2031) & (US$ Million)

Table 53. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 54. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2020-2025) & (US$ Million)

Table 55. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size by Country (2026-2031) & (US$ Million)

Table 56. Invitae Company Details

Table 57. Invitae Business Overview

Table 58. Invitae Amyotrophic Lateral Sclerosis Gene Testing Product

Table 59. Invitae Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025) & (US$ Million)

Table 60. Invitae Recent Development

Table 61. Quest Diagnostics Company Details

Table 62. Quest Diagnostics Business Overview

Table 63. Quest Diagnostics Amyotrophic Lateral Sclerosis Gene Testing Product

Table 64. Quest Diagnostics Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025) & (US$ Million)

Table 65. Quest Diagnostics Recent Development

Table 66. Labcorp Company Details

Table 67. Labcorp Business Overview

Table 68. Labcorp Amyotrophic Lateral Sclerosis Gene Testing Product

Table 69. Labcorp Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025) & (US$ Million)

Table 70. Labcorp Recent Development

Table 71. GeneDx Company Details

Table 72. GeneDx Business Overview

Table 73. GeneDx Amyotrophic Lateral Sclerosis Gene Testing Product

Table 74. GeneDx Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025) & (US$ Million)

Table 75. GeneDx Recent Development

Table 76. Centogene Company Details

Table 77. Centogene Business Overview

Table 78. Centogene Amyotrophic Lateral Sclerosis Gene Testing Product

Table 79. Centogene Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025) & (US$ Million)

Table 80. Centogene Recent Development

Table 81. Fulgent Genetics Company Details

Table 82. Fulgent Genetics Business Overview

Table 83. Fulgent Genetics Amyotrophic Lateral Sclerosis Gene Testing Product

Table 84. Fulgent Genetics Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025) & (US$ Million)

Table 85. Fulgent Genetics Recent Development

Table 86. Ambry Genetics Company Details

Table 87. Ambry Genetics Business Overview

Table 88. Ambry Genetics Amyotrophic Lateral Sclerosis Gene Testing Product

Table 89. Ambry Genetics Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025) & (US$ Million)

Table 90. Ambry Genetics Recent Development

Table 91. Baylor Genetics Company Details

Table 92. Baylor Genetics Business Overview

Table 93. Baylor Genetics Amyotrophic Lateral Sclerosis Gene Testing Product

Table 94. Baylor Genetics Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025) & (US$ Million)

Table 95. Baylor Genetics Recent Development

Table 96. Mayo Clinic Laboratories Company Details

Table 97. Mayo Clinic Laboratories Business Overview

Table 98. Mayo Clinic Laboratories Amyotrophic Lateral Sclerosis Gene Testing Product

Table 99. Mayo Clinic Laboratories Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025) & (US$ Million)

Table 100. Mayo Clinic Laboratories Recent Development

Table 101. NEALS Consortium Labs Company Details

Table 102. NEALS Consortium Labs Business Overview

Table 103. NEALS Consortium Labs Amyotrophic Lateral Sclerosis Gene Testing Product

Table 104. NEALS Consortium Labs Revenue in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025) & (US$ Million)

Table 105. NEALS Consortium Labs Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Amyotrophic Lateral Sclerosis Gene Testing Picture

Figure 2. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Amyotrophic Lateral Sclerosis Gene Testing Market Share by Type: 2024 VS 2031

Figure 4. Targeted ALS Gene Panel Features

Figure 5. Single-Gene Features

Figure 6. Whole Exome Sequencing Features

Figure 7. Whole Genome Sequencing Features

Figure 8. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Comparison by Product Type (2020-2031) & (US$ Million)

Figure 9. IVD Kits Features

Figure 10. Diagnostic Instruments Features

Figure 11. Other Features

Figure 12. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size Comparison by Sample (2020-2031) & (US$ Million)

Figure 13. Blood/Serum Features

Figure 14. Saliva Features

Figure 15. Other Features

Figure 16. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 17. Global Amyotrophic Lateral Sclerosis Gene Testing Market Share by Application: 2024 VS 2031

Figure 18. Hospitals Case Studies

Figure 19. Third-party Laboratory Case Studies

Figure 20. Others Case Studies

Figure 21. Amyotrophic Lateral Sclerosis Gene Testing Report Years Considered

Figure 22. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 23. Global Amyotrophic Lateral Sclerosis Gene Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 24. Global Amyotrophic Lateral Sclerosis Gene Testing Market Share by Region: 2024 VS 2031

Figure 25. Global Amyotrophic Lateral Sclerosis Gene Testing Market Share by Players in 2024

Figure 26. Global Amyotrophic Lateral Sclerosis Gene Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 27. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Gene Testing Revenue in 2024

Figure 28. North America Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. North America Amyotrophic Lateral Sclerosis Gene Testing Market Share by Country (2020-2031)

Figure 30. United States Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Canada Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Europe Amyotrophic Lateral Sclerosis Gene Testing Market Share by Country (2020-2031)

Figure 34. Germany Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. France Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. U.K. Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Italy Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Russia Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Ireland Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Amyotrophic Lateral Sclerosis Gene Testing Market Share by Region (2020-2031)

Figure 42. China Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Japan Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. South Korea Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. India Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Australia & New Zealand Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Latin America Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Latin America Amyotrophic Lateral Sclerosis Gene Testing Market Share by Country (2020-2031)

Figure 50. Mexico Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Brazil Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Middle East & Africa Amyotrophic Lateral Sclerosis Gene Testing Market Share by Country (2020-2031)

Figure 54. Israel Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. UAE Amyotrophic Lateral Sclerosis Gene Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Invitae Revenue Growth Rate in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

Figure 58. Quest Diagnostics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

Figure 59. Labcorp Revenue Growth Rate in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

Figure 60. GeneDx Revenue Growth Rate in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

Figure 61. Centogene Revenue Growth Rate in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

Figure 62. Fulgent Genetics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

Figure 63. Ambry Genetics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

Figure 64. Baylor Genetics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

Figure 65. Mayo Clinic Laboratories Revenue Growth Rate in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

Figure 66. NEALS Consortium Labs Revenue Growth Rate in Amyotrophic Lateral Sclerosis Gene Testing Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4R20263

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Online Speech Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39V19943

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Nerve Repair and Regeneration Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-10C17235

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Neurological Disease Model Chip Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-7M17348

Thu Nov 06 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Amyotrophic Lateral Sclerosis Gene Testing Market Research Report 2025

Published Date: November 2025

Report Code: QYRE-Auto-4R20263

Global Amyotrophic Lateral Sclerosis Gene Testing Market Research Report 2025

FEATURED COMPANIES

Amyotrophic Lateral Sclerosis Gene Testing Market Size

Amyotrophic Lateral Sclerosis Gene Testing Market

Scope of Amyotrophic Lateral Sclerosis Gene Testing Market Report

Chapter Outline

FAQ for this report

How fast is Amyotrophic Lateral Sclerosis Gene Testing Market growing?

What is the Amyotrophic Lateral Sclerosis Gene Testing Market size in 2031?

Who are the main players in the Amyotrophic Lateral Sclerosis Gene Testing Market report?

What are the Application segmentation covered in the Amyotrophic Lateral Sclerosis Gene Testing Market report?

What are the Type segmentation covered in the Amyotrophic Lateral Sclerosis Gene Testing Market report?

FEATURED COMPANIES

RELATED REPORTS